SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Åvall Lundqvist Elisabeth) ;spr:swe"

Sökning: WFRF:(Åvall Lundqvist Elisabeth) > Svenska

  • Resultat 1-6 av 6
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bergmark, K, et al. (författare)
  • A Swedish study of women treated for cervix cancer. Gynecologic cancer often affects sexuality
  • 2000
  • Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 97:46
  • Tidskriftsartikel (refereegranskat)abstract
    • Gynecological cancer and its treatments are often associated with physical, psychological and social consequences that affect the woman's and the couple's sexuality. Especially due to their impact on sexuality, physical changes distress the women considerably, and warrant consideration for women of all ages. Women with gynecological cancer ask for information about possible side-effects of the disease and treatment that can affect the sexual function. At follow-up visits these issues can be attended to through information, with specific suggestions including advice about topical estrogen and dilators, to alleviate possible long-term sequelae.
  •  
2.
  • Högberg, Thomas, et al. (författare)
  • Gynekologisk onkologi
  • 2008. - 2
  • Ingår i: Onkologi. - Stockholm : Liber. - 9789147084012 ; , s. 488-533
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
3.
  • Högberg, Thomas, et al. (författare)
  • Hopp om förbättring av överlevnad i ovarialcancer
  • 2015
  • Ingår i: Läkartidningen. - : Läkartidningen Förlag AB. - 0023-7205 .- 1652-7518. ; 112:50, s. 2281-3
  • Tidskriftsartikel (refereegranskat)abstract
    • Ovarian cancer is the most common cause of death from a gynecologic cancer. Every year around 700 women contracts ovarian cancer in Sweden. The overall survival is among the highest in Europe, but still long term relative survival is only 46%. It is a long-held myth that ovarian cancer is a disease without symptoms. Almost 90% of women have symptoms, even in the early stages. Symptoms that should arise suspicion of ovarian cancer and initiate diagnostic work-up are continuous abdominal extension, early feeling of satiety, pelvic or abdominal pain, urinary urge and postmenopausal bleeding. Women's awareness of symptoms and willingness to seek medical advice and the organization of the health care system are important factors determining cancer survival. Ovarian cancer is a heterogeneous group of diseases with different tumor traits and prognosis. Personalized medicine and preventive measures recognizing recent knowledge about tumor biology will positively affect survival.
  •  
4.
  • Högberg, Thomas, et al. (författare)
  • Hopp om förbättring av överlevnad i ovarialcancer
  • 2015
  • Ingår i: Läkartidningen. - : Läkartidningen Förlag AB. - 1652-7518 .- 0023-7205. ; 112
  • Tidskriftsartikel (refereegranskat)abstract
    • Ovarian cancer is the most common cause of death from a gynecologic cancer. Every year around 700 women contracts ovarian cancer in Sweden. The overall survival is among the highest in Europe, but still long term relative survival is only 46%. It is a long-held myth that ovarian cancer is a disease without symptoms. Almost 90% of women have symptoms, even in the early stages. Symptoms that should arise suspicion of ovarian cancer and initiate diagnostic work-up are continuous abdominal extension, early feeling of satiety, pelvic or abdominal pain, urinary urge and postmenopausal bleeding. Women's awareness of symptoms and willingness to seek medical advice and the organization of the health care system are important factors determining cancer survival. Ovarian cancer is a heterogeneous group of diseases with different tumor traits and prognosis. Personalized medicine and preventive measures recognizing recent knowledge about tumor biology will positively affect survival.
  •  
5.
  • Kjölhede, Preben, et al. (författare)
  • Individualiserad behandling vid ovarialcancer kan bli möjlig
  • 2015
  • Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 112:50, s. 2281-3
  • Tidskriftsartikel (refereegranskat)abstract
    • Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy in developed countries. Several promising steps toward individualized therapy have been taken recently due to increased knowledge of molecular biology. Multidisciplinary conferences for treatment planning and the centralization to tertiary surgical centers improve quality of surgery and survival. The primary treatment of EOC is radical surgery followed by adjuvant chemotherapy with carboplatin and paclitaxel. Bevacizumab added to the chemotherapy and used as maintenance treatment is standard in the primary treatment of patients with residual tumor or inoperable patients. The PARP inhibitor olaparib is recommended as maintenance treatment of women with platinum sensitive relapsed BRCA mutated high-grade serous EOC who have responded to platinum-based chemotherapy. BRCA testing should be offered to women with EOC. In platinum-resistant recurrence addition of bevacizumab to chemotherapy should be considered.
  •  
6.
  • Åvall Lundqvist, Elisabeth (författare)
  • Paradigmskifte för gynekologisk cancer
  • 2015
  • Ingår i: Läkartidningen. - : Läkartidningen Förlag AB. - 0023-7205 .- 1652-7518. ; 112:50, s. 2271-
  • Tidskriftsartikel (refereegranskat)abstract
    • Med ökad förståelse för bakomliggande mekanismer har ett genombrott skett vad gäller behandling och förståelse av gynekologisk cancer. I år godkändes den första målriktade behandlingen vid gynekologisk cancer, och därmed blir individualiserad behandling en realitet.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-6 av 6

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy